drugset / Trial / NCT00531193

Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers

NCT00531193 ↗

Phase 1 Completed 32 enrolled Biogen
Non-randomizedSingle-groupOpen-labelBasic science

Summary

To establish the extent to which BIIB014, following 8 to 12 consecutive days of dosing at selected dose levels, occupies the brain's A2A receptors. Receptor occupancy will be assessed by PET scanning using a radiolabelled tracer.

Timeline

Start
2007-09
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject VIPADENANT Small molecule — Oral

Indications

No indication recorded.